You are here: Industry Insights > SSc

News List

New products to drive systemic sclerosis market to $1.8 bn by 2030: GlobalData expresspharma
June 21, 2021
GlobalData expects Ofev and Actemra/RoActemra to reach peak global sales of $508.8 million in 2025 and $163.2 million in 2024, respectively.
Diagnosed prevalent cases of systemic sclerosis in 7MM to reach 187,000 by 2030: GlobalData expresspharma
June 04, 2021
The US will have the highest number of diagnosed prevalent cases of systemic sclerosis in the 7MM at 114,000.
Lenabasum Study for Systemic Sclerosis Does Not Meet Primary Endpoint americanpharmaceuticalreview
September 23, 2020
Corbus Pharmaceuticals has announced topline results from the 52-week Phase 3 RESOLVE-1 study of lenabasum in patients with diffuse cutaneous systemic sclerosis (SSc). SSc is a rare and life-threatening multi-system autoimmune disease for which there ...
Genomics reveals key macrophages’ involvement in systemic sclerosis biospectrumasia
November 19, 2018
Published in the Annals of Rheumatic Diseases (ARD), in addition to confirming many genes previously implicated in the genetic predisposition to the disease